Retargeting of T cells to prostate stem cell antigen expressing tumor cells: Comparison of different antibody formats

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Target-dependent T-cell Activation by Coligation With a PSMA×CD3 Diabody Induces Lysis of Prostate Cancer Cells

(2009) Patrick Bühler et al.   JOURNAL OF IMMUNOTHERAPY

Prostate stem cell antigen: A prospective therapeutic and diagnostic target

(2008) Adam B. Raff et al.   CANCER LETTERS

Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells

(2008) Sandrine d’Argouges et al.   LEUKEMIA RESEARCH

Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody

(2008) R. Bargou et al.   SCIENCE

Advances in Specific Immunotherapy for Prostate Cancer

(2007) Andrea Kiessling et al.   EUROPEAN UROLOGY